Contributor Disclosures for Melanotic Neuroectodermal Tumor of Infancy
Role Name Disclosure Details
Author James Burns, DDS, MSEd, PhD, Chairman, Professor, Department of Oral and Maxillofacial Pathology, Medical College of Virginia School of Dentistry Nothing to discloseDetails
Coauthor Robert Strauss, DDS, Associate Professor, Department of Oral and Maxillofacial Surgery, Medical College of Virginia-Virginia Commonwealth University Nothing to discloseDetails
Medical Editor Mark G Lebwohl, MD, Chairman, Department of Dermatology, Mount Sinai School of Medicine Abbott Laboratories
Actelion
Amgen
Astellas
Basilea
Briston-Myers Squibb
Celtic Pharma
Centocor
Chattem
DermiPsor
DOV
Galderma
Genentech
Genzyme
Graceway
Helix BioMedix
Medicis
Novartis
OMP
Pfizer
PharmaDerm
Stiefel
Teva
UCB
Warner Chilcott
Peplin
Ranbaxy
Details
Pharmacy Editor Richard P Vinson, MD, Assistant Clinical Professor, Department of Dermatology, Texas Tech University School of Medicine; Consulting Staff, Mountain View Dermatology, PA Nothing to discloseDetails
Managing Editor Drore Eisen, MD, DDS, Consulting Staff, Department of Dermatology, Dermatology Research Associates of Cincinnati Nothing to discloseDetails
CME Editor Glen H Crawford, MD, Assistant Clinical Professor, Department of Dermatology, University of Pennsylvania School of Medicine; Chief, Division of Dermatology, The Pennsylvania Hospital Nothing to discloseDetails
Chief Editor William D James, MD, Paul R Gross Professor of Dermatology, University of Pennsylvania School of Medicine; Vice-Chair, Program Director, Department of Dermatology, University of Pennsylvania Health System elsevier
american college of physicians
Details









Contributor:
Contributor Disclosure:
James Burns, Author  The contributor discloses no conflict of interest. 









Contributor Disclosure


Contributor:
Contributor Disclosure:
Robert Strauss, Coauthor  The contributor discloses no conflict of interest. 






 

CONTRIBUTOR DISCLOSURE FORM


Contributor Name:
Mark G Lebwohl

 DECLARATION STATEMENT
I and/or my spouse/partner have no financial interest with any organization that could be perceived as a real or apparent conflict of interest in the context of the subject of this activity.
I and/or my spouse/partner have a financial interest/arrangement with one or more organization(s), including but not limited to the organization(s) supporting this activity, that could be perceived as a real or apparent conflict of interest in the context of the subject of this activity.
COMMERCIAL INTEREST
(Name of Organization)
Self
Spouse/
Partner
NATURE OF RELEVANT FINANCIAL RELATIONSHIP
What was received?*
For what role?**

Abbott Laboratories
HonorariaConsulting 
Actelion
HonorariaConsulting 
Amgen
HonorariaConsulting 
Astellas
HonorariaConsulting 
Basilea
HonorariaConsulting 
Briston-Myers Squibb
HonorariaConsulting 
Celtic Pharma
HonorariaOther 
Centocor
HonorariaConsulting 
Chattem
HonorariaOther 
DermiPsor
HonorariaConsulting 
DOV
HonorariaConsulting 
Galderma
HonorariaConsulting 
Genentech
HonorariaConsulting 
Genzyme
HonorariaConsulting 
Graceway
HonorariaConsulting 
Helix BioMedix
HonorariaConsulting 
Medicis
HonorariaInvestigator 
Novartis
HonorariaConsulting 
OMP
HonorariaOther 
Pfizer
HonorariaConsulting 
PharmaDerm
HonorariaOther 
Stiefel
HonorariaConsulting 
Teva
HonorariaConsulting 
UCB
HonorariaConsulting 
Warner Chilcott
HonorariaConsulting 
Peplin
HonorariaConsulting 
Ranbaxy
HonorariaConsulting 
Off label or investigational use of medication






 

CONTRIBUTOR DISCLOSURE FORM


Contributor Name:
Richard P Vinson

 DECLARATION STATEMENT
I and/or my spouse/partner have no financial interest with any organization that could be perceived as a real or apparent conflict of interest in the context of the subject of this activity.
I and/or my spouse/partner have a financial interest/arrangement with one or more organization(s), including but not limited to the organization(s) supporting this activity, that could be perceived as a real or apparent conflict of interest in the context of the subject of this activity.
COMMERCIAL INTEREST
(Name of Organization)
Self
Spouse/
Partner
NATURE OF RELEVANT FINANCIAL RELATIONSHIP
What was received?*
For what role?**

Off label or investigational use of medication






 

CONTRIBUTOR DISCLOSURE FORM


Contributor Name:
Drore Eisen

 DECLARATION STATEMENT
I and/or my spouse/partner have no financial interest with any organization that could be perceived as a real or apparent conflict of interest in the context of the subject of this activity.
I and/or my spouse/partner have a financial interest/arrangement with one or more organization(s), including but not limited to the organization(s) supporting this activity, that could be perceived as a real or apparent conflict of interest in the context of the subject of this activity.
COMMERCIAL INTEREST
(Name of Organization)
Self
Spouse/
Partner
NATURE OF RELEVANT FINANCIAL RELATIONSHIP
What was received?*
For what role?**

Off label or investigational use of medication









Contributor Disclosure


Contributor:
Contributor Disclosure:
Glen H Crawford, CME Editor  The contributor discloses no conflict of interest. 






 

CONTRIBUTOR DISCLOSURE FORM


Contributor Name:
William D James

 DECLARATION STATEMENT
I and/or my spouse/partner have no financial interest with any organization that could be perceived as a real or apparent conflict of interest in the context of the subject of this activity.
I and/or my spouse/partner have a financial interest/arrangement with one or more organization(s), including but not limited to the organization(s) supporting this activity, that could be perceived as a real or apparent conflict of interest in the context of the subject of this activity.
COMMERCIAL INTEREST
(Name of Organization)
Self
Spouse/
Partner
NATURE OF RELEVANT FINANCIAL RELATIONSHIP
What was received?*
For what role?**

elsevier
RoyaltyOther 
american college of physicians
HonorariaOther 
Off label or investigational use of medication